INTRODUCTION
The modified nucleoside, queuosine (Q), replaces guanosine (G) in tRNAcuN, accommodating the amino acids asparagine, aspartic acid, histidine and tyrosine, in almost all eubacteria and eukaryotes (reviewed in [1] [2] [3] . Although this modification at position 34 in the anticodon has been highly conserved in the course of evolution, only eubacteria can synthesize Q in tRNA de novo, involving unique S-adenosylmethionine and vitamin B12 dependent reactions (4) (5) (6) . Degradation of bacterial tRNAsQUN (Q-tRNAs) liberates the eukaryotic nutrition factor, queuine, the free base analogue of Q in tRNA (because queuine is present in eukaryotes as free base and as modified nucleoside in tRNA, we use the abbreviation 'q' or 'q-base' to denote the free base, and 'Q' for the modified nucleoside in tRNA). Mammals are supplied with q-base by their diet or gut flora, and cultured cells by the addition of fetal or newborn serum to the culture medium. The eukaryotic tRNA:guanine transglycosylase (referred to as TGT; EC 2.4.2.29; also designated as tRNA:guanine ribosyltransferase) replaces guanine in tRNAcuN with queuine in a unique base-for-base exchange reaction without breakage of the sugar phosphate backbone of tRNA (1, 2) . Insertion of the q-base into tRNA and liberation of guanine takes place in the cytosol of the cell.
Although the presence of Q-tRNAs is not vital for mammals and other eukaryotes (3, 7) , the q-base and/or Q-tRNAs participate in the fine-tuning of many cellular functions such as differentiation (8, 9) , the control of the aerobic/anaerobic energy metabolism (3, 10) , the management of hypoxic stress (11, 12) , the regulation of protein synthesis (13) especially during re-entry of cells into the cell cycle (11), the adaptive regulation of cell proliferation to the metabolic predisposition (14) , and the modulation of signal transduction pathways (15, 16) . Moreover, the q-base is essential for the adaptive regulation of cell proliferation to aerobiosis or hypoxia in HeLa cells (14) .
Tumor cells frequently contain considerable amounts of -deficient tRNA), whereas a complete conversion to Q is found in normal terminally differentiated somatic cells (2, 3) . Characteristic fluctuations in the extent to which tRNAscuN are converted to tRNAsQUN also occur during differentiation (8) . A connection between the appearance of Q-deficient tRNA and the initiation and/or maintenance of neoplastic transformation has been postulated (17) (18) (19) . However, the reasons for the appearance of Q-deficient tRNAs in tumor cells are not well understood. Apparently, availability of the substrate q is not the limiting factor, because q was found in tumor cells in sufficient amounts, while a significant portion of the tRNAs remained Q-deficient (3). Increased amounts of pteridines in tumor cells-competitive inhibitors of the eukaryotic TGTmay be connected to hypomodification of Q-tRNAs (3). It was described that the TGT enzyme needs oxygen for maximal activity (10) , suggesting that hypoxia may be a reason for the lack of TGT activity in tumor cells. Reduced expression of the tgt gene in one tumor cell line has been described (18) , which also causes Q-deficiency of tRNA. A role for protein kinase C (a multi-functional serine/threonine kinase involved in signal transduction from the cell surface to the nucleus) in the regulation of q-uptake into mammalian cells was postulated by Elliott and co-workers * To whom correspondence should be addressed suggesting a connection between the metabolism of queuine and signal transduction and/or growth control (20, 21) .
Recently, we described that the q-base is not inserted into tRNA in hypoxically grown HeLa cells under conditions where serum factors become depleted from the culture medium (12) . Using these culture conditions, we have investigated how the TGT enzyme might be regulated in tumor cells. Here we provide evidence that the tRNA:guanine transglycosylase of HeLa cells was inactive under hypoxic conditions when serum factors became limiting. It could be reactivated by the phorbol ester TPA, an activator of protein kinase C. This reactivation did not depend on mRNA or protein synthesis, suggesting that the eukaryotic TGT is a downstream target of protein kinase C under certain conditions.
MATERIALS AND METHODS
HeLa S3 cells (American Type Culture Collection) were grown in Minimum Essential Medium (MEM; BioWhittaker, Germany) supplemented with 10% q-free horse serum (Boehringer, Mannheim, Germany) (3) in an atmosphere of 95% air and 5% CO2 (aerobic conditions corresponding to 21% oxygen content). To create hypoxic conditions, cells were grown in an incubator in which the oxygen content was reduced to 7% by replacement of the atmosphere with nitrogen. The process of insertion of queuine into tRNA was analysed under two different conditions: (a) Cells were seeded in 10 cm culture dishes (5 x 1 Oddish) and cultivated for 3 days. The medium was then replaced with fresh medium containing 300 nM q-base. Cells were harvested at different times after addition of the q-base (5-10 dishes for each analysis) and bulk tRNA was isolated as described (12) . The amount of Q-deficient tRNAscuN was determined using the E.coli tRNA:guanine transglycosylase (22) . This enzyme catalyses the specific exchange of guanine at position 34 of the anticodon of tRNAscuN (the Q-family of tRNAs) for H]guanine. The guanine acceptance is maximal when the tRNAs are completely Q-deficient (0% modification found in tRNA from HeLa cells grown in horse serum-supplemented medium), and is 0 when the tRNAs are completely converted to tRNAquN (100% modification), (b) Cells were seeded as described under (a) and cultivated for 4 days with an exchange of the medium on the second day. Queuine alone (300 nM) or together with PDGF (final concentration 40 ng/ml; Biomol, Germany) and/or EGF (30 nM; Biomol, Germany) or with 12-0-tetradecanoylphorbol-13-acetate (TPA; 15 |iM; Sigma, Germany) was added on day 4 without exchange of the medium and tRNA was isolated 24 h later. Cycloheximide (10 ng/ml; Sigma, Germany) and a-amanitin (4 (ig/ml; Sigma, Germany) were added 1 h before TPA. Protein free extracts from similar grown cells were prepared and the intracellular concentration of the free q-base was measured as described (12) . Mouse EAT cells (Dr A. Ogilvie, Erlangen, Germany), human A-431 cells (ATCQ, human Colo-DM320 cells (Dr T. Dingermann, Frankfurt, Germany), rat PC-12 cells (ATCQ and mouse N1H-3T3 fibroblasts transformed with the activated N-ras gene (kindly provided by Dr M. Terada, National Cancer Center Research Institute, Tokyo, Japan) were seeded as HeLa cells and grown for 2-3 days. RPMJ1640 medium (Gibco-BRL, Germany) was used for EAT cells and DMEM medium (Biochrom, Germany) for the other cells. The q-base was added (300 nM) and the intracellular concentration of q was analysed 24 h later.
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time after addition of q (hours) Figure 1 . Concentration of the q-base (A) and extent of modification of Q-tRNAs (B) in aerobically and hypoxically grown HeLa cells. Cells were precultivated for 2 days in q-free medium under aerobic (-O-) or hypoxic (-9-) conditions. The medium was then replaced with fresh medium and cells were further incubated Queuine (q) was added to the cells (300 nM) either together with fresh medium on the second day (condition a) or 2 days after replacement of the medium (condition b). Bulk tRNA was isolated at the noted times after addition of q-base and the extent to which tRNAsouN were converted to tRNAsQUN was analysed as described in Materials and Methods (B). The intracellular concentration of the q-base was determined in protein free extracts from similar grown cells (A).
RESULTS
HeLa cells grown in medium supplemented with q-free horse serum do not contain the modified nucleoside queuosine in tRNA (referred to as q-deficient cells) (3). The process of insertion of the q-base into tRNA catalysed by the TGT enzyme was analyzed by adding chemically synthesized q-base to these cells. HeLa cells were inoculated in horse serum-supplemented medium for 2 days. The medium was then replaced with fresh serum-supplemented medium containing 300 nM q-base (condition a in Fig.  1 ). Cells were further incubated and bulk tRNA was isolated at various times after addition of the q-base. The extent to which tRNAscuN were converted to IRNAQLTN was analysed using the transglycosylase assay (22) . Experiments were performed under aerobic (21% oxygen) and hypoxic conditions (7% oxygen). Protein-free extracts from similar grown cells were used to determine the intracellular concentration of free q.
Appearance of the modified nucleoside queuosine in tRNA was detectable already 1 h after addition of the q-base to q-deficient cells (Fig. IB) . However, modification was incomplete (40% of the total amount of tRNAcuN modified) even 24 h after q-addition (70% modified), the period of most active proliferation. Almost complete conversion of tRNAscuN to tRNAQUN was found 3 days after addition of the q-base, when cells had reached a high density and proliferation slowed down. The extent of modification of Q-tRNAs was the same in aerobically and in hypoxically grown cells, except for a slight reduction (10%) in hypoxically grown cells 72 hours after q-addition.
The q-base was added to the culture medium to a final concentration of 300 nM. However, the intracellular concentration of the q-base reached a 5-6-fold higher level compared with the culture medium already 2 h after q-addition, indicating a massive accumulation of this base against the concentration gradient (Fig.  1 A) . The intracellular concentration of the q-base declined to lower levels between 24 and 72 h after q-addition but always remained higher than the concentration of q in the culture medium, independent of the respective culture condition. Clearly, hypomodification of Q-tRNAs during the period of most active proliferation is not due to the lack of substrate for the TGT enzyme.
In a different type of experiments, HeLa cells were grown as described above, however, q was not added together with serum but 48 h after replacement of the medium when cells already had reached a high density (condition b in Fig. 1 ). The extent of modification of Q-tRNAs was analysed 24 h later. The q-base was incorporated into tRNA in aerobically grown cells to an extent comparable to the one that was observed when q-base was added together with serum (Fig. IB) . However, the tRNAs of hypoxically grown cells remained completely Q-deficient The free q-base accumulated in HeLa cells also under these culture conditions: the intracellular concentration of the q-base was 2-fold higher in aerobically grown cells and even 7-fold higher in hypoxically grown cells than in the culture medium (Fig. 1 A) . Therefore, the inability of hypoxically grown HeLa cells to insert the q-base into tRNAs under the above described conditions is not due to a lack of substrate but rather to the lack of activity of the TGT enzyme.
High amounts of free q-base are found in embryonic cells and tissues and in some solid tumors (3) . To answer the question as to whether intracellular accumulation of the q-base is associated with the transformed phenotype of mammalian tumor cells, we analysed the intracellular concentration of q in five other transformed cell lines that were supplemented with 300 nM q-base. It is shown in Table 1 that cell lines of various origin and morphology were not able to increase the intracellular concentration of q above the concentration in the culture medium, with the possible exception of EAT cells which showed a slight accumulation. The results described above indicated that insertion of the q-base into tRNA in hypoxically grown HeLa cells depends on the availability of some unknown serum factor(s). We therefore tested the ability of two polypeptide growth factors, known to be present in serum, to restore TGT activity under hypoxic conditions: treatment of cells with platelet derived growth factor (PDGF) did not restore modification of Q-tRNAs (Fig. 2) . In the presence of the q-base and epidermal growth factor (EGF), however, the tRNAs of the Q-family became modified to 30% within 8 h. When PDGF and EGF were added together, the tRNAs of the Q-family were modified to the same extent as in serum-supplemented medium 24 h after q-addition (compare Fig.  IB) . Binding of polypeptide growth factors to their receptors initiates a signalling cascade that often involves activation of protein kinase C (PKC). This kinase can also be activated by phorbol esters such as TPA. When TPA was added to HeLa cells under hypoxic conditions, modification of Q-tRNAs was completely restored (Fig. 2) , suggesting a role for PKC in the control of TGT activity. So far, the experiments did not allow to decide whether restoration of TGT activity involves expression of the corresponding gene or of cofactors that can modulate its activity. Hypoxically grown HeLa cells were therefore treated with TPA in the presence of the protein synthesis inhibitor cycloheximide, or the RNA polymerase inhibitor a-amanitin. Both inhibitors did not prevent insertion of the q-base into tRNA, suggesting that neither protein synthesis nor mRNA synthesis is needed to restore TGT activity with activators of PKC under hypoxic conditions (Fig. 2) .
DISCUSSION
The q-base, an eukaryotic nutrition factor, is liberated from bacterially synthesized tRNAquN after degradation. Mammals are supplied with q-base by their diet or gut flora (1) , and the free q-base is transported to the cells via the blood stream. To be able to incorporate die q-base into tRNAs, cells must take up q across the plasma membrane. Uptake of q apparently involves a specific uptake system that can be influenced by growth factors and activators of protein kinase C (21,22) . Strikingly, high concentra-tions of the q-base are frequently found in embryonic cells and tissues such as Xenopus oocytes (1 (iM) and wheat germ (1 uM), and in some solid tumors (0.5-0.7 (iM), suggesting that these cells are able to accumulate q (3). Here we showed that the q-base accumulated in HeLa cells against the concentration gradient, suggesting that these cells use an active transport system for this base. However, no such accumulation of the q-base was found in other cell lines and, therefore, appears to be a rather specific feature of HeLa cells. Probably, this transport system for the q-base is normally expressed during embryogenesis, and is part of the defects that cause disregulation of cell proliferation and differentiation in certain tumor cells. HeLa cells are a suitable model system to investigate this transport system for q.
The insertion of q into tRNA is the only transglycosylation that occurs in the cytosol of the cell. Previous results suggested that this reaction is subject to regulation, because considerable portions of Q-deficient tRNAsouN are found in tumor cells although the q-base is present in relatively high concentrations (3). Here we showed that the TGT enzyme was always active in aerobically grown HeLa cells. Insertion of the q-base into tRNA occurred even in serum-free medium (results not shown), suggesting that the TGT enzyme is not subject to regulation in aerobically grown HeLa cells. However, conversion of tRNAscuN to tRNAsQUN was incomplete during the period of most active proliferation, although sufficient amounts of q-base were present in these cells. This indicates that, in the case of HeLa cells, the synthesis of tRNAs during proliferation is faster than the process of insertion of the q-base into newly synthesized tRNA. Probably, low TGT activity and fast proliferation can account for incomplete modification of Q-tRNAs in certain tumor cells.
Under hypoxic conditions, when cells become glycolytic (14) , q was no longer inserted into tRNA when serum factors became limiting. Apparently, this was not caused by reduced oxygen tension, because q was inserted into tRNA when given to cells together with serum under the same conditions. TGT activity rather depended on the availability of serum factors, but hypoxia was a prerequisite for this regulation by exogenous factors, because no such dependence was found under aerobic conditions. Here we showed that certain growth factors such as EGF restored TGT activity, suggesting that tRNA modification with queuine and regulation of cell proliferation are connected via signal transduction pathways. Activation of protein kinase C (PKQ was sufficient to restore full activity of the TGT enzyme, suggesting an involvement of this multifunctional kinase in the control of tRNA modification with q. Probably, the reactivation of TGT by growth factors involves signalling from the growth factor receptor via PKC to this tRNA modifying enzyme. This assumption is confirmed by the observation that the reactivation of TGT by TPA did not depend on gene transcription or mRNA translation, suggesting that the enzyme was present but inactive. It was observed by Morris et al. (see accompanying paper) that TGT (TGRase) is regulated by PKC also in vitro; PKC catalysed incorporation of phosphate into an inactive TGT preparation and reconstituted activity, whereas phosphatases deminished TGT activity. The results indicate that the human tRNA modifying enzyme, TGT, is a direct or indirect downstream target of PKC, and is regulated by reversible phosphorylation. Cloning of the gene encoding the mammalian TGT is currently in progress. This will finally allow us to investigate in detail how protein kinase C regulates this tRNA-modifying enzyme.
